Preclinical and clinical development of a YFV 17 D-based chimeric vaccine against West Nile virus. - Wikidata - wikimedia - TriplyDB

Preclinical and clinical development of a YFV 17 D-based chimeric vaccine against West Nile virus.

Preclinical and clinical development of a YFV 17 D-based chimeric vaccine against West Nile virus.

http://www.wikidata.org/entity/Q37666763

about

Aedes mosquitoes and Zika virus infection: an A to Z of emergence?Approved Antiviral Drugs over the Past 50 Years Plant-made vaccines against West Nile virus are potent, safe, and economically feasible HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV.Current trends in West Nile virus vaccine development.Live virus vaccines based on a yellow fever vaccine backbone: standardized template with key considerations for a risk/benefit assessment Current developments in understanding of West Nile virus central nervous system disease.RNA-based viral vectors.Technologies for the development of West Nile virus vaccines.An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection.

P2860

Q24261313-2BE3C720-155A-4A77-AC22-CAF7BBA4455C Q27755387-7E3FEA75-7711-4699-87E8-900E8951771A Q28082778-6890D00D-F617-4C8B-AD52-7AB299E3FA23 Q33869332-CBC9ABF3-E272-4D39-B517-6C6B1F0A5843 Q34788758-47FACE76-9A1D-41AB-8D9A-DE5CF3FA119C Q36307457-C5782C76-8F98-47E4-8C2C-C13BDBBF3599 Q38203769-F6672784-8819-4118-BFAD-D2464AC46DCB Q38266413-99C7592C-0058-4FAC-95F1-C8AB22B9413D Q38269151-210DCD34-DDCC-4CFD-8E7E-97028DB11099 Q38866173-E996CE1F-2822-49EE-823F-837AD1DA92FB

P2860

Preclinical and clinical development of a YFV 17 D-based chimeric vaccine against West Nile virus.

http://www.wikidata.org/entity/Q37666763

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Preclinical and clinical devel ...... ccine against West Nile virus.

@en

Preclinical and clinical devel ...... ccine against West Nile virus.

@nl

type

label

Preclinical and clinical devel ...... ccine against West Nile virus.

@en

Preclinical and clinical devel ...... ccine against West Nile virus.

@nl

prefLabel

Preclinical and clinical devel ...... ccine against West Nile virus.

@en

Preclinical and clinical devel ...... ccine against West Nile virus.

@nl

P1433

Q37666763-0049ADEB-6119-40C7-9E54-3D968DA7617A

P1476

Q37666763-E0E078C8-FDC5-425F-8562-2E2D713CC511

P2093

Q37666763-E2277978-CB78-47CA-95E6-B312B0F3A1B7

Q37666763-EB358304-13C3-4D51-842D-7A54C39A79C0

Q37666763-F94D6F19-E6EC-4D2E-99E6-DC963AF3F898

P275

Q37666763-63122FE6-2303-4499-AE41-88C476B976B4

P2860

Q37666763-00C80388-92CD-4C6C-9A8D-5ED5F9DB30A3

Q37666763-00EC9E08-3FDF-4645-9BED-66BFE60F1CB6

Q37666763-018EC8A1-9E92-4426-8012-9F7C4FA2F3BC

Q37666763-18E3C613-FA80-4330-83D2-2733CA4B11F5

Q37666763-1B533BC6-FF4D-4910-BA18-CAAD407C6FDD

Q37666763-1FCFE43E-D3C7-467E-81C3-248D47CFC648

Q37666763-244AF1A4-E0F1-4C62-8DD7-AB5C4A6EC584

Q37666763-260A238A-55B4-4E87-9342-A27C5FD0C53F

Q37666763-27CA31D2-3174-482B-BAA3-03ECF12ACC70

Q37666763-32ECDAB0-3139-4A1D-B26F-BCFAC373B7AC

P304

Q37666763-1C5FF1B3-4CBA-4AC9-84EA-F323FBCC3BDE

P31

Q37666763-BF033AD4-324A-48C5-B5CB-36E2862ACDDA

Q37666763-FC802655-2B15-4307-A6E7-A3CCD5B48176

P356

Q37666763-F1961981-75A7-45C6-8E7E-B15A3D7240E7

P433

Q37666763-A12CBF12-03FC-4EC4-BE60-12F5ADABD82C

P478

Q37666763-5A63806F-AE8F-46D5-B6B3-C937E0580C09

P50

Q37666763-0E63EE50-B7DC-4941-8827-317B981AA76C

Q37666763-FD1EA1A2-2839-4C55-812C-330E549B75EC

P5008

Q37666763-13B01D16-FD25-4026-85D8-EDD89B583DBC

P577

Q37666763-B05CCE35-B4E1-41EF-904B-02D0392B8241

P5875

Q37666763-FFC51C64-CBD5-405D-A208-6AE24DF356E5

P698

Q37666763-1B2402D7-9075-4FF7-BE04-5861898A3171

P921

Q37666763-7C682860-4503-45C1-B420-F5ECD12583BF

Q37666763-958F0BEA-65F0-4DEC-8A67-AA08B97642C7

Q37666763-F3519A60-446E-470E-A671-2ECA5B83F138

P932

Q37666763-A5BFC4F6-1B78-4939-9E4C-765039359523

P356

P1433

P1476

Preclinical and clinical devel ...... ccine against West Nile virus.

@en

P2093

Jean Lang

http://www.w3.org/2001/XMLSchema#string

Joan Bevilacqua

http://www.w3.org/2001/XMLSchema#string

Konstantin Pugachev

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Prevalence of chronic kidney disease and progression of disease over time among patients enrolled in the Houston West Nile virus cohort

Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).

A live, attenuated recombinant West Nile virus vaccine.

Comparative Efficacies of Three Commercially Available Vaccines against West Nile Virus (WNV) in a Short-Duration Challenge Trial Involving an Equine WNV Encephalitis Model

Substitution of wild-type yellow fever Asibi sequences for 17D vaccine sequences in ChimeriVax-dengue 4 does not enhance infection of Aedes aegypti mosquitoes

Vector Competence of Selected North American Culex and Coquillettidia Mosquitoes for West Nile Virus

Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection

Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model

A Prospective Nested Case-Control Study of Dengue in Infants: Rethinking and Refining the Antibody-Dependent Enhancement Dengue Hemorrhagic Fever Model

Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States

P304

3048-3070

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/V5123048

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Thomas P. Monath

Gustavo H Dayan

P5008

P577

2013-12-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259386616

http://www.w3.org/2001/XMLSchema#string

P698

24351795

http://www.w3.org/2001/XMLSchema#string

P921

West Nile virus

pharmaceutical preparation

P932

3967160

http://www.w3.org/2001/XMLSchema#string